About

Dr. Karin Lachmi is a highly accomplished entrepreneur and scientist with over 15 years of experience in the field of life sciences. She is the Chief Scientific Officer and Founder of Bioz, a groundbreaking startup that leverages the power of artificial intelligence (AI) to accelerate research in the biopharma and academic sectors. Under her leadership, Bioz has become the world's most advanced AI search engine for life science experimentation, providing scientists with evidence-based product recommendations based on real-world experiments described in over 500 million pages of scientific text. Prior to founding Bioz, Dr. Lachmi served as the Managing Director of the Tel Aviv Sourasky Medical Center US (TASMC/Ichilov) and worked as a neuroscientist and researcher at Stanford University. She earned her Ph.D. in cancer research from Tel Aviv University, where she also completed her undergraduate degree in biology. Dr. Lachmi is a highly decorated entrepreneur and scientist, having won numerous awards and recognition for her work. She was named C-suite/CSO of the year by the Silicon Valley Business Journal in 2017, and was also recognized as one of the most influential women in Silicon Valley that same year. In 2016, she won the Stevie Award for Female Entrepreneur of the Year. She is also an Official Contributor Member of Forbes and serves as a Startup Judge, Advisor, Speaker & Panel Member for startx. Dr. Lachmi's expertise in AI, deep learning, NLP, ML, neural networks, and search has been instrumental in the development of Bioz's proprietary technology. Her team of software engineers, led by AI experts from Microsoft and Google and Nobel Prize winners in chemistry, have created an AI system that is 84 times faster than traditional experimentation methods. By accelerating the pace of experiments, Bioz is able to increase the speed of drug discovery by as much as 56%, resulting in billions of research dollars saved. Overall, Dr. Karin Lachmi is a visionary entrepreneur and scientist who has made significant contributions to the field of life sciences. Her leadership and expertise have been instrumental in the success of Bioz, and her innovative approach to research has the potential to revolutionize the biopharma and academic sectors.